Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management
Sign Up to like & getrecommendations! Published in 2020 at "Current Oncology Reports"
DOI: 10.1007/s11912-020-00931-w
Abstract: Purpose of Review Multiple myeloma is the second most common hematologic malignancy in the USA, with over 32,000 new cases and nearly 13,000 deaths expected in 2019. The past few decades in myeloma research have… read more here.
Keywords: proteasome inhibitor; related cardiotoxicity; cardiotoxicity mechanisms; cardiotoxicity ... See more keywords